分子靶向药及PD-1/PD-L1抑制药在肝癌系统治疗中的现状及进展
Current status and recent advances of molecular targeted drugs and PD-1/PD-L1 inhibitors in systemic therapy of hepatocellular carcinoma
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |